FDG PET- CT SUVmax and IASLC/ATS/ERS histologic classification: a new profile of lung adenocarcinoma with prognostic value

Quantitative analysis of glucose consumption measured by maximum standardized uptake value (SUVmax) in lung adenocarcinoma (LA) remains in discussion and metabolic information provided by FDG-PET is not included in cancer staging. The first aim of this work was to evaluate the correlation between SU...

ver descrição completa

Detalhes bibliográficos
Autores: Suárez-Piñera, Marina, Belda, José, Taus García, Álvaro, Sánchez-Font, Albert, Mestre-Fusco, Antoni, Jiménez, Marcel, Pijuan Andujar, Lara
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2018
País:España
Recursos:Universitat Pompeu Fabra
Repositorio:Repositorio Digital de la UPF
OAI Identifier:oai:repositori.upf.edu:10230/36667
Acesso em linha:http://hdl.handle.net/10230/36667
Access Level:acceso abierto
Palavra-chave:18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET)
Lung adenocarcinoma
Histologic classification
Maximum standardized uptake value (SUVmax)
Prognostic
Staging
id ES_a9277d5e600ca18ec2d7ff1cfc2b6d0d
oai_identifier_str oai:repositori.upf.edu:10230/36667
network_acronym_str ES
network_name_str España
repository_id_str
spelling FDG PET- CT SUVmax and IASLC/ATS/ERS histologic classification: a new profile of lung adenocarcinoma with prognostic valueSuárez-Piñera, MarinaBelda, JoséTaus García, ÁlvaroSánchez-Font, AlbertMestre-Fusco, AntoniJiménez, MarcelPijuan Andujar, Lara18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET)Lung adenocarcinomaHistologic classificationMaximum standardized uptake value (SUVmax)PrognosticStagingQuantitative analysis of glucose consumption measured by maximum standardized uptake value (SUVmax) in lung adenocarcinoma (LA) remains in discussion and metabolic information provided by FDG-PET is not included in cancer staging. The first aim of this work was to evaluate the correlation between SUVmax and different histologic subtypes of LA. The second aim was to establish the correlation between SUVmax and TNM, genetic mutations and prognostic. Glucose consumption of primary tumor was quantified using SUVmax in 112 patients with histologically-confirmed LA. Specimens were classified according to the IASLC/ATS/ERS into in situ -AIS-, minimally invasive -MIA-, invasive (lepidic, papillary, acinar, solid and micropapillary) and invasive mucinous adenocarcinoma. Tumors were grouped according to three histological grades; low-grade: AIS, MIA, intermediate-grade: lepidic, acinar, papillary and high-grade: micropapillary, solid and mucinous. Comparisons between SUVmax and histologic subtypes were performed with Kruskal-Wallis followed by a Dunn's test. Overall (OS) and disease-free survival (DFS) were calculated. SUVmax was histologically-dependent (P<0.001): AIS 0.5±0.1, MIA 1.1±0.9 lepidic 3.3±3.1, acinar 8.6±6.7, papillary 3.9±5.1, micropapillary 4.9±3.4, solid 10.4±5.4 and invasive mucinous 2.7±1.2. SUVmax was associated with TNM stage in stage IA and IB. SUVmax was significantly lower in patients with K-RAS and EGFR mutation. Low SUVmax was associated with low-grade histology and with a higher OS and DSF compared to high SUVmax (intermediate and high-grade histology). SUVmax on FDG-PET is a powerful information in the presurgical evaluation of LA patients. It provides prognostic data and should be considered in the staging algorithm of patients with LA.e-Century Publishing201920192018info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttp://hdl.handle.net/10230/36667reponame:Repositorio Digital de la UPFinstname:Universitat Pompeu FabraInglésAmerican Journal of Nuclear Medicine and Molecular Imaging. 2018 Apr 25;8(2):100-9AJNMMI Copyright © 2018. Articles from American Journal of Nuclear Medicine and Molecular Imaging are provided here courtesy of e-Century Publishing Corporationinfo:eu-repo/semantics/openAccessoai:repositori.upf.edu:10230/366672026-06-12T07:21:37Z
dc.title.none.fl_str_mv FDG PET- CT SUVmax and IASLC/ATS/ERS histologic classification: a new profile of lung adenocarcinoma with prognostic value
title FDG PET- CT SUVmax and IASLC/ATS/ERS histologic classification: a new profile of lung adenocarcinoma with prognostic value
spellingShingle FDG PET- CT SUVmax and IASLC/ATS/ERS histologic classification: a new profile of lung adenocarcinoma with prognostic value
Suárez-Piñera, Marina
18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET)
Lung adenocarcinoma
Histologic classification
Maximum standardized uptake value (SUVmax)
Prognostic
Staging
title_short FDG PET- CT SUVmax and IASLC/ATS/ERS histologic classification: a new profile of lung adenocarcinoma with prognostic value
title_full FDG PET- CT SUVmax and IASLC/ATS/ERS histologic classification: a new profile of lung adenocarcinoma with prognostic value
title_fullStr FDG PET- CT SUVmax and IASLC/ATS/ERS histologic classification: a new profile of lung adenocarcinoma with prognostic value
title_full_unstemmed FDG PET- CT SUVmax and IASLC/ATS/ERS histologic classification: a new profile of lung adenocarcinoma with prognostic value
title_sort FDG PET- CT SUVmax and IASLC/ATS/ERS histologic classification: a new profile of lung adenocarcinoma with prognostic value
dc.creator.none.fl_str_mv Suárez-Piñera, Marina
Belda, José
Taus García, Álvaro
Sánchez-Font, Albert
Mestre-Fusco, Antoni
Jiménez, Marcel
Pijuan Andujar, Lara
author Suárez-Piñera, Marina
author_facet Suárez-Piñera, Marina
Belda, José
Taus García, Álvaro
Sánchez-Font, Albert
Mestre-Fusco, Antoni
Jiménez, Marcel
Pijuan Andujar, Lara
author_role author
author2 Belda, José
Taus García, Álvaro
Sánchez-Font, Albert
Mestre-Fusco, Antoni
Jiménez, Marcel
Pijuan Andujar, Lara
author2_role author
author
author
author
author
author
dc.subject.none.fl_str_mv 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET)
Lung adenocarcinoma
Histologic classification
Maximum standardized uptake value (SUVmax)
Prognostic
Staging
topic 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET)
Lung adenocarcinoma
Histologic classification
Maximum standardized uptake value (SUVmax)
Prognostic
Staging
description Quantitative analysis of glucose consumption measured by maximum standardized uptake value (SUVmax) in lung adenocarcinoma (LA) remains in discussion and metabolic information provided by FDG-PET is not included in cancer staging. The first aim of this work was to evaluate the correlation between SUVmax and different histologic subtypes of LA. The second aim was to establish the correlation between SUVmax and TNM, genetic mutations and prognostic. Glucose consumption of primary tumor was quantified using SUVmax in 112 patients with histologically-confirmed LA. Specimens were classified according to the IASLC/ATS/ERS into in situ -AIS-, minimally invasive -MIA-, invasive (lepidic, papillary, acinar, solid and micropapillary) and invasive mucinous adenocarcinoma. Tumors were grouped according to three histological grades; low-grade: AIS, MIA, intermediate-grade: lepidic, acinar, papillary and high-grade: micropapillary, solid and mucinous. Comparisons between SUVmax and histologic subtypes were performed with Kruskal-Wallis followed by a Dunn's test. Overall (OS) and disease-free survival (DFS) were calculated. SUVmax was histologically-dependent (P<0.001): AIS 0.5±0.1, MIA 1.1±0.9 lepidic 3.3±3.1, acinar 8.6±6.7, papillary 3.9±5.1, micropapillary 4.9±3.4, solid 10.4±5.4 and invasive mucinous 2.7±1.2. SUVmax was associated with TNM stage in stage IA and IB. SUVmax was significantly lower in patients with K-RAS and EGFR mutation. Low SUVmax was associated with low-grade histology and with a higher OS and DSF compared to high SUVmax (intermediate and high-grade histology). SUVmax on FDG-PET is a powerful information in the presurgical evaluation of LA patients. It provides prognostic data and should be considered in the staging algorithm of patients with LA.
publishDate 2018
dc.date.none.fl_str_mv 2018
2019
2019
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10230/36667
url http://hdl.handle.net/10230/36667
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv American Journal of Nuclear Medicine and Molecular Imaging. 2018 Apr 25;8(2):100-9
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv e-Century Publishing
publisher.none.fl_str_mv e-Century Publishing
dc.source.none.fl_str_mv reponame:Repositorio Digital de la UPF
instname:Universitat Pompeu Fabra
instname_str Universitat Pompeu Fabra
reponame_str Repositorio Digital de la UPF
collection Repositorio Digital de la UPF
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869415978552524800
score 15,811543